You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage IB vulvar cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Female Reproductive System Tumor, Stage I Cervical Cancer AJCC v8, Stage I Uterine Corpus Cancer AJCC v8 Trial in

Recruiting
  • Malignant Female Reproductive System Neoplasm
  • +44 more
  • Counseling
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 25, 2022

Lymphedema, Perioperative/Postoperative Complications, Stage IA Vulvar Cancer AJCC v7 Trial in United States (Bioelectric

Completed
  • Lymphedema
  • +9 more
  • Bioelectric Impedance Analysis
  • +2 more
  • Little Rock, Arkansas
  • +10 more
May 4, 2021

Lymphedema, Stage 0 Cervical Cancer, Stage 0 Uterine Corpus Cancer Trial in Philadelphia (Management of Therapy Complications,

Terminated
Has Results
  • Lymphedema
  • +18 more
  • Management of Therapy Complications
  • Quality-of-Life Assessment
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Jun 11, 2021

Cervical Adenocarcinoma, Cervical Adenocarcinoma In Situ, Cervical Intraepithelial Neoplasia Trial in Houston (Biospecimen

Recruiting
  • Cervical Adenocarcinoma
  • +54 more
  • Biospecimen Collection
  • Laboratory Biomarker Analysis
  • Houston, Texas
  • +1 more
Nov 30, 2020

SLN Mapping and ICG Dye for Vulvar Cancer

Not yet recruiting
  • Vulva Cancer
  • Indocyanine green
  • Boston, Massachusetts
    Tufts Medical Center
Sep 6, 2023

Vulvar Cancer Trial in Catania (Sentinel lymph node mapping with indocyanine green fluorescence imaging in vulvar cancer (FIGO

Recruiting
  • Vulvar Cancer
  • Sentinel lymph node mapping with indocyanine green fluorescence imaging in vulvar cancer (FIGO Stage IB)
  • Catania, Italy
    Ginecologia e Ostetricia
Dec 6, 2020

Stage IB Non-small Cell Lung Cancer

Completed
  • Stage IB Non-Small Cell Lung Carcinoma
    • Shanghai, China
      180 Fenglin Road
    Jul 29, 2023

    Malignant Female Reproductive System Tumor, Stage III Cervical Cancer AJCC v8, Stage III Ovarian Cancer AJCC v8 Trial in Duarte

    Not yet recruiting
    • Malignant Female Reproductive System Neoplasm
    • +10 more
    • Discussion
    • +4 more
    • Duarte, California
      City of Hope Medical Center
    Mar 24, 2023

    Stage III Vulvar Cancer, Stage III Ovarian Cancer, Stage III Uterine Cancer Trial in Indianapolis (Intervention group triads)

    Enrolling by invitation
    • Stage III Vulvar Cancer
    • +7 more
    • Intervention group triads
    • Indianapolis, Indiana
      Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
    Aug 10, 2023

    NSCLC, EGFR Sensitive Mutation, Adjuvant Therapy Trial in Beijing, Nanjing, Shanghai (Befotertinib + Icotinib , Icotinib +

    Recruiting
    • Non-Small Cell Lung Cancer
    • +2 more
    • Befotertinib + Icotinib placebo
    • Icotinib + Befotertinib placebo
    • Beijing, China
    • +2 more
    Sep 20, 2023

    Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial in

    Recruiting
    • Anatomic Stage 0 Breast Cancer AJCC v8
    • +23 more
    • Quality-of-Life Assessment
    • +2 more
    • Jacksonville, Florida
      Mayo Clinic in Florida
    Nov 9, 2022

    Limited Stage Small Cell Lung Cancer, Not Progressed After First-line Chemoradiotherapy Trial in Jinan (TQB2450 Injection +

    Recruiting
    • Limited Stage Small Cell Lung Cancer
    • Not Progressed After First-line Chemoradiotherapy
    • TQB2450 Injection + Anlotinib Hydrochloride Capsules
    • Jinan, Shandong, China
      Cancer Hospital Affiliated to Shandong First Medical University
    Jul 5, 2023

    Extensive-stage Small Cell Lung Cancer Trial in Tianjin (Selinexor,Olaparib)

    Recruiting
    • Extensive-stage Small Cell Lung Cancer
    • Tianjin, China
      Tianjin Medical University Cancer Institute and Hospital
    Jul 27, 2023

    Small Cell Lung Cancer Extensive Stage Trial in Jinan, Tianjin, Zhengzhou (IN10018, Tislelizumab, Carboplatin)

    Not yet recruiting
    • Small Cell Lung Cancer Extensive Stage
    • Jinan, China
    • +2 more
    Sep 10, 2023

    NSCLC Trial (Furmonertinib)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • (no location specified)
    Jul 5, 2022

    Extensive Stage Small Cell Lung Cancer Trial (hSTC810 400 mg + Paclitaxel, hSTC810 800 mg + Paclitaxel)

    Not yet recruiting
    • Extensive Stage Small Cell Lung Cancer
    • hSTC810 400 mg + Paclitaxel
    • hSTC810 800 mg + Paclitaxel
    • (no location specified)
    Aug 24, 2023

    Hepatocellular Carcinoma, Lenvatinib, Tislelizumab Trial in Hangzhou (TACE, Tislelizumab, Lenvatinib)

    Not yet recruiting
    • Hepatocellular Carcinoma
    • +5 more
    • TACE
    • Tislelizumab, Lenvatinib
    • Hangzhou, Zhejiang, China
      1# Banshan East Rd. Zhejiang cancer hospital
    Jun 17, 2023

    Human Papilloma Virus Circulating Tumor DNA in Cervical Cancer

    Recruiting
    • Cervical Adenosquamous Carcinoma
    • +26 more
    • Biospecimen Collection
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 4, 2023

    Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial in

    Recruiting
    • Anatomic Stage 0 Breast Cancer AJCC v8
    • +16 more
    • Anhydrous Enol-oxaloacetate
    • Questionnaire Administration
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    Dec 1, 2022

    NSCLC Trial in Celebration, Detroit, Durham (GT103)

    Recruiting
    • Non-small Cell Lung Cancer
    • Celebration, Florida
    • +2 more
    Nov 22, 2022

    NSCLC Trial in Philadelphia (Sotorasib, 960 mg, oral daily dose for 4 weeks (28 days))

    Recruiting
    • Non-Small Cell Lung Cancer
    • Sotorasib, 960 mg, oral daily dose for 4 weeks (28 days)
    • Philadelphia, Pennsylvania
      Fox Chase Cancer Center
    Jul 29, 2022

    Small Cell Lung Cancer Trial (SC0245, Irinotecan)

    Not yet recruiting
    • Small Cell Lung Cancer
    • (no location specified)
    Feb 7, 2023

    Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial in

    Recruiting
    • Anatomic Stage 0 Breast Cancer AJCC v8
    • +21 more
    • Behavioral, Psychological or Informational Intervention
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 30, 2023

    NSCLC Trial in Guangzhou (SBRT, Tislelizumab)

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    May 17, 2022

    Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

    Recruiting
    • Anatomic Stage I Breast Cancer AJCC v8
    • +20 more
    • Best Practice
    • +2 more
    • Jacksonville, Florida
      Mayo Clinic in Florida
    Jan 5, 2023